Enter your zip code here

mobile site / full site Your MNT
login | registerhome
opinions forum
contact us
news categories:
a – b
Acid Reflux / GERD
Aid / Disasters
Alcohol / Addiction / Drugs
Alternative Medicine
Alzheimer’s / Dementia
Anxiety / Stress
Arthritis / Rheumatology
Asbestos / Mesothelioma
Back Pain
Bio-terrorism / Terrorism
Biology / Biochemistry
Bird Flu / Avian Flu
Blood / Hematology
Body Aches
Bones / Orthopaedics
Breast Cancer

c – d
Cancer / Oncology
Cardiovascular / Cardiology
Caregivers / Homecare
Cervical Cancer / HPV Vaccine
CJD / vCJD / Mad Cow Disease
Cleft Palate
Clinical Trials / Drug Trials
Colorectal Cancer
Complementary Medicine
Cosmetic Medicine
Cystic Fibrosis
Drug Approvals

e – g
Ear, Nose and Throat
Eating Disorders
Eczema / Psoriasis
Erectile Dysfunction
Eye Health / Blindness
Flu / Cold / SARS
Food Intolerance
h – l
Headache / Migraine
Health Insurance
Hearing / Deafness
Heart Disease
Huntingtons Disease
Immune System / Vaccines
Infectious Diseases
Inflammatory Bowel Disease
Irritable Bowel Syndrome
IT / Internet / E-mail
Liver Disease / Hepatitis
Lung Cancer
Lymphology / Lymphedema
Lymphoma / Leukemia
m – o
Medical Devices / Diagnostics
Medical Malpractice
Medical Practice Management
Medical Students / Training
Medicare / Medicaid / SCHIP
Melanoma / Skin Cancer
Men’s Health
Mental Health
MRI / PET / Ultrasound
MRSA / Drug Resistance
Multiple Sclerosis
Muscular Dystrophy / ALS
Neurology / Neuroscience
Nursing / Midwifery
Nutrition / Diet
Obesity / Weight Loss / Fitness
Ovarian Cancer

p – r
Pain / Anesthetics
Palliative Care / Hospice Care
Pancreatic Cancer
Parkinson’s Disease
Pediatrics / Children’s Health
Pharma / Biotech Industry
Pharmacy / Pharmacist
Plastic Surgery
Pregnancy / Obstetrics
Premature Ejaculation
Preventive Medicine
Primary Care / General Practice
Prostate / Prostate Cancer
Psychology / Psychiatry
Public Health
Radiology / Nuclear Medicine
Regulatory Affairs
Restless Legs Syndrome

s – z
Seniors / Aging
Sexual Health / STDs
Sleep / Sleep Disorders
Smoking / Quit Smoking
Sports Medicine / Fitness
Stem Cell Research
Swine Flu
Transplants / Organ Donations
Tropical Diseases
Urology / Nephrology
Veterans / Ex-Servicemen
Viruses / Bacteria
Water – Air Quality / Agriculture
Women’s Health

Some “Good” Cholesterol May Be Bad For Heart
Featured Article
Academic Journal
Main Category: Cholesterol
Also Included In: Heart Disease; Cardiovascular / Cardiology
Article Date: 20 May 2012 – 6:00 PDT

email to a friend printer friendly opinions Current ratings for:
‘Some “Good” Cholesterol May Be Bad For Heart’

Patient / Public: 4.38 (8 votes)

Healthcare Prof: 4.8 (5 votes)

It appears that in some cases, high-density lipoprotein (HDL) cholesterol, the so-called “good” cholesterol, does not protect against heart disease, and may even be harmful. A new study suggests a subclass of HDL that carries a particular protein is bad for the heart.

Previous studies have shown that high levels of HDL cholesterol are strongly linked to low risk of heart disease. But trials where people have been given drugs to increase their levels of HDL cholesterol have yielded inconsistent results: leading to the idea that HDL cholesterol may actually have protective and non-protective elements.

Now, researchers at the Harvard School of Public Health (HSPH) have found that when the surface of HDL cholesterol bears a small protein called apolipoprotein C-III (apoC-III), there is an increase in the risk of heart disease, and when it is absent, HDL cholesterol is especially heart protective.

They write about their study, the first to show this effect, in a recent online issue of the Journal of the American Heart Association.

Senior author Frank Sacks is professor of cardiovascular disease prevention at HSPH. He told the press:

“This finding, if confirmed in ongoing studies, could lead to better evaluation of risk of heart disease in individuals and to more precise targeting of treatments to raise the protective HDL or lower the unfavorable HDL with apoC-III.”

ApoC-III is a proinflammatory protein that resides on the surface of some lipoproteins, including HDL and LDL (low-density lipoprotein, or “bad”) cholesterol.

For their investigation, Sacks and colleagues examined blood samples from 18,225 men and 32,826 women who took part in the Health Professionals Follow-up Study, and the Brigham and Women’s Hospital-based Nurses’ Health Study between 1989 and 1995.

They wanted to see whether apoC-III made a difference to the heart-protective qualities of HDL cholesterol: they wondered if there were two subclasses of HDL cholesterol, one that protected against heart disease and one that did not, depending on the presence of apoC-III.

The study participants had been followed for 10 to 14 years, during which time 634 of them developed coronary heart disease. Sacks and colleagues matched these participants with controls who had the same demographic status (eg age and gender), smoking status, and whose blood samples were drawn at the same time.

They compared the blood samples in several different ways: they looked at total HDL, HDL with apoC-III, and HDL without apoC-III, and assessed these concentrations against coronary heart disease (CHD) risk.

They also adjusted the results so as to eliminate, as far as possible, effects from other factors that impact CHD risk, such as age, smoking status, diet and lifestyle.

The results showed that after taking these potential influencers into account, two subclasses of HDL cholesterol appear to have opposite effects on risk of CHD in men and women.

A minor subclass, accounting for around 13% of HDL cholesterol, carries apoC-III and this was linked to a higher risk of future CHD.

The major subclass of HDL cholesterol is one that does not carry apoC-III, and this was linked to a lower risk of future CHD.

The analysis showed the participants with plasma HDL apoC-III concentrations in the highest 20% of the population had a 60% increased risk of CHD.

The researchers suggest rather than simply measuring total HDL, it might be better to measure HDL with and without apoC-III to provide a more reliable gauge of heart disease risk, or the protective capacity of HDL.

Jensen also proposed that:

“Reduction in HDL-apoC-III by diet or drug treatments may become an indicator of efficacy.”

Funds from The National Institutes of Health and the Villum Kann Rasmussen Foundation in Denmark helped pay for the study.

This is not the only study recently to doubt the heart-protective benefit of HDL cholesterol. A paper by Sekar Kathiresan of Massachusetts General Hospital in Boston, and colleagues, published in the The Lancet on 17 May, questions the idea that raising blood HDL cholesterol translates into reduced risk of heart attack.

Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our cholesterol section for the latest news on this subject.
“Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease”; Majken K. Jensen, Eric B. Rimm, Jeremy D. Furtado, and Frank M. Sacks; J Am Heart Assoc. 2012; 1: jah3-e000232; DOI:10.1161/JAHA.111.000232; Link to Abstract.
Additional source:Harvard School of Public Health
Please use one of the following formats to cite this article in your essay, paper or report:

Catharine Paddock PhD. “Some “Good” Cholesterol May Be Bad For Heart.” Medical News Today. MediLexicon, Intl., 20 May. 2012. Web.
23 May. 2012.
Catharine Paddock PhD. (2012, May 20). “Some “Good” Cholesterol May Be Bad For Heart.” Medical News Today. Retrieved from

Please note: If no author information is provided, the source is cited instead.

20Rate article:
(Hover over the stars then click to rate) Patient / Public:
12345 or Health Professional:

Ads by Google

Lower Your LDL Level – Get Tips on How to Manage and Reduce Your High Cholesterol Here. – merckengage.com